Pharma & Biotech
VolitionRx’s Nu.Q cancer-screening blood tests could replace colonoscopies, biopsies
BioPorto focused on flagship NGAL acute kidney-injury test but also looking at coronavirus test
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.